Home > Analytics > INDRAPRASTHA MEDICAL CORPORATION

INDRAPRASTHA MEDICAL CORPORATION
Intrinsic Value | Fundamental Analysis

BOM : 532150     NSE : INDRAMEDCO    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Dec 02,2022
Price(EOD): ₹ 85.30
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Hospital & Healthcare Services
MCap: ₹ 782.20 Cr
Value of ₹ 1 Lac invested in INDRAPRASTHA MEDICAL CORPORATION
on Dec 04,2017 (price: ₹ 52.85)

₹ 1 L

₹ 1.61 L

1W : 0.4% 1M : 22% 1Y : 9.9%
COMMUNITY POLL
for INDRAPRASTHA MEDICAL CORPORATION
Please provide your vote to see the results
INDRAPRASTHA MEDICAL CORPORATION is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
INDRAPRASTHA MEDICAL CORPORATION 0.4% 22% 9.9%
APOLLO HOSPITALS ENTERPRISE 3.2% 11.2% -16.1%
MAX HEALTHCARE INSTITUTE 1.8% -3.7% 19%
DR LAL PATHLABS 2.3% -6% -35.8%
FORTIS HEALTHCARE -1.3% 3% 3.6%
METROPOLIS HEALTHCARE 0.7% -15.4% -55.2%
ASTER DM HEALTHCARE 0.4% -11.9% 20.9%
NARAYANA HRUDAYALAYA 1.4% -1.5% 25.9%
KRISHNA INSTITUTE OF MEDICAL SCIENCES 1.2% 0.4% 22.7%

FUNDAMENTAL ANALYSIS OF INDRAPRASTHA MEDICAL CORPORATION

 
Fundamentals Score
[ Q(TTM): Sep2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF INDRAPRASTHA MEDICAL CORPORATION

 
Valuation Score
[As on : Dec 02,2022 ]

Ratio Standalone
P/E
P/B
P/S
10.22
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 76.53 Cr
[Latest Qtr - Sep2022 - Standalone Results ]

2.4
P/B Calculated based on Book Value of Rs 325.44 Cr
[Latest Year - Mar2022 - Standalone Results ]

0.78
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2022 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 16% undervalued companies ! Discover More →

FAIR VALUE OF INDRAPRASTHA MEDICAL CORPORATION

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
17%
14%
34%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF INDRAPRASTHA MEDICAL CORPORATION


Insights 💡 INDRAMEDCO is one of the top 33% companies with bullish price momentum currently! Discover More →

INDRAPRASTHA MEDICAL CORPORATION vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF INDRAPRASTHA MEDICAL CORPORATION

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0
0
0.01
-
-
-
-
-
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF INDRAPRASTHA MEDICAL CORPORATION

Pledged Promoter Shares
0 %
As on : Sep2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF INDRAPRASTHA MEDICAL CORPORATION

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
7.99%
18.16%
25.84%
23.92%
22.1%
71.92%
107.82%
108.03%
QtrlyTrend
8
Latest Qtr: Sep2022
Quarterly Result Analysis →


INDRAPRASTHA MEDICAL CORPORATION related INDICES

BSE Indices1W1M1Y
S&P BSE MIDSMALLCAP 2.6% 3.1% 7.8%
S&P BSE SMALL CAP 2.4% 3.5% 8.6%
S&P BSE ALLCAP 1.6% 2.7% 9.4%
S&P BSE HEALTHCARE 1.1% -1.6% -6.1%
No NSE index found

You may also like the below Video Courses


FAQ about INDRAPRASTHA MEDICAL CORPORATION


Is INDRAPRASTHA MEDICAL CORPORATION good for long term investment?

As on Dec 02,2022, the Fundamentals of INDRAPRASTHA MEDICAL CORPORATION look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of INDRAPRASTHA MEDICAL CORPORATION . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is INDRAPRASTHA MEDICAL CORPORATION UnderValued or OverValued?

As on Dec 02,2022, INDRAPRASTHA MEDICAL CORPORATION is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of INDRAPRASTHA MEDICAL CORPORATION ?

As on Dec 02,2022, the Intrinsic Value of INDRAPRASTHA MEDICAL CORPORATION is Rs. 73.11 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 73.11
Fair Value [Median EV / Sales Model] : Rs. 74.95
Fair Value [Median Price / Sales Model] : Rs. 63.86
Estimated Median Fair Value of INDRAPRASTHA MEDICAL CORPORATION : Rs. 73.11

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is INDRAPRASTHA MEDICAL CORPORATION trading at a Premium or Discount?

As on Dec 02,2022, INDRAPRASTHA MEDICAL CORPORATION is trading at a Premium of 17% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].